Novel Thiourea and Oxime Ether Isosteviol-Based Anticoagulants: MD Simulation and ADMET Prediction
Activated blood coagulation factor X (FXa) plays a critical initiation step of the blood-coagulation pathway and is considered a desirable target for anticoagulant drug development. It is reversibly inhibited by nonvitamin K antagonist oral anticoagulants (NOACs) such as apixaban, betrixaban, edoxab...
में बचाया:
मुख्य लेखकों: | Marcin Gackowski (लेखक), Mateusz Jędrzejewski (लेखक), Sri Satya Medicharla (लेखक), Rajesh Kondabala (लेखक), Burhanuddin Madriwala (लेखक), Katarzyna Mądra-Gackowska (लेखक), Renata Studzińska (लेखक) |
---|---|
स्वरूप: | पुस्तक |
प्रकाशित: |
MDPI AG,
2024-01-01T00:00:00Z.
|
विषय: | |
ऑनलाइन पहुंच: | Connect to this object online. |
टैग: |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
समान संसाधन
-
Ether Derivatives of Naringenin and Their Oximes as Factors Modulating Bacterial Adhesion
द्वारा: Anna Duda-Madej, और अन्य
प्रकाशित: (2023) -
Thiourea Derivatives as Estrogen Receptor Alpha Inhibitors for Breast Cancer Therapy: An In Silico Evaluation with ADMET Prediction and Molecular Docking
द्वारा: Hestining Puspaweni, और अन्य
प्रकाशित: (2024) -
Isosteviol: A potential cardioprotective agent
द्वारा: Jovanović Aleksandar
प्रकाशित: (2024) -
New 2-Aryl-1,4-naphthoquinone-1-oxime Methyl Ether Compound Induces Microtubule Depolymerization and Subsequent Apoptosis
द्वारा: Hiromi Sato, और अन्य
प्रकाशित: (2012) -
Erythrocyte Partitioning Profile of Isosteviol in Human and Rat Blood
द्वारा: Ayorinde Adehin, PhD, और अन्य
प्रकाशित: (2019)